We observed a dose-dependent decrease in PAH levels upon a dose-dependent increase in Cdh1 suggesting that Cdh1 destabilizes and degrades PAH protein (Figure 2B). The gene discussed is CDH1; the disease is pulmonary arterial hypertension.